J&J Immunology President On Remicade, Inflectra And The Art Of Contract Negotiations
Executive Summary
Janssen Biotech's Immunology President Scott White defended the company's Remicade contracting strategy in an interview and outlined why J&J believes it has been unfairly targeted in an anti-competitive lawsuit filed by rival Pfizer.